华海药业(600521.SH)发预减，预计2025年度归母净利润2.24亿元至3.35亿元，同比降低70%到80%

Core Viewpoint - Huahai Pharmaceutical (600521.SH) expects a significant decrease in net profit for the fiscal year 2025, projecting a range between 224 million yuan and 335 million yuan, which represents a decline of approximately 70% to 80% compared to the previous year [1] Financial Performance - The company anticipates a reduction in net profit attributable to shareholders of approximately 78.398 million yuan to 89.498 million yuan compared to the same period last year [1]